Abstract
The sensitive detection of circulating tumour cells in patients with differentiated thyroid cancer may precede the detection of relapse by other diagnostic studies – such as serum thyroglobulin – and thus may have important therapeutic and prognostic implications. We performed reverse transcription-polymerase chain reaction (RT-PCR) on blood samples from patients diagnosed with thyroid disease using two different RT-PCR sensitivities. Additionally, tissue specificity of TG mRNA-expression was determined using RNA extracts from 27 different human tissues. The lower limit of detection was 50–100 TG mRNA producing cells/ml blood using a ‘normal’ RT-PCR sensitivity and 10–20 cells/ml blood using a ‘high’ sensitivity. With the normal sensitivity TG mRNA was detected in 9/13 patients with thyroid cancer and metastasis, 63/137 patients with a history of thyroid cancer and no metastasis, 21/85 with non-malignant thyroid disease and 9/50 controls. With the high sensitivity TG mRNA was detected in 11/13 patients with thyroid cancer and metastasis, 111/137 patients with a history of thyroid cancer and no metastasis, 61/85 with non-malignant thyroid disease and 41/50 controls. Interestingly, using the normal RT-PCR sensitivity TG mRNA transcripts are specific for thyroid tissue and detectable in the peripheral blood of controls and patients with thyroid disease, which correlates with a diagnosis of metastasized thyroid cancer. However, with a high RT-PCR sensitivity, TG mRNA expression was found not to be specific for thyroid tissue and was not correlated with a diagnosis of thyroid cancer in patients. As a consequence, to date TG mRNA detected by RT-PCR in the peripheral blood cannot be recommended as a tumour marker superior to TG serum-level. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403–410
Aust G, Crisp M, Bosenberg E, Ludgate M, Weetman AP and Paschke R (1998) Transcription of thyroid autoantigens in non-expressing tissues. Exp Clin Endocrinol Diabetes 106: 319–323
Bellantone R, Lombardi CP, Boscherini M, Ferrante A, Raffaelli M, Rubino F, Bossola M and Crucitti F (1998) Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 68: 237–241
Chelly J, Concordet JP, Kaplan JC and Kahn A (1989) Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 86: 2617–2621
Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH and Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475–482
Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C and Gerfo PL (1996) Detection of circulating thyroid cells in peripheral blood. Surgery 120: 959–965
Gerfo PL, Colacchio T, Colacchio D and Feind C (1979) Thyroglobulin in benign and malignant thyroid disease. JAMA 241: 923–924
Ghossein RA and Rosai J (1996) Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78: 10–16
Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF and Rosai J (1995) Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implication. J Clin Oncol 13: 1195–1200
Haber RS (1998) Editorial: The diagnosis of recurrent thyroid cancer – a new approach. J Clin Endocrinol Metab 83: 4189–4190
Herle AJ and Uller RP (1975) Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 56: 272–277
Hoang-Vu C, Dralle H, Scheumann G, Maenhaut C, Horn R, von zur Mühlen, and Brabant G (1992) Gene expression of differentiation and dedifferentiation markers in normal and malignant human thyroid tissues. Exp Clin Endocrinol Diabetes 100: 51–56
Johnson PWM, Burchill SA and Selby PJ (1995) The molecular detection of circulating tumor cells. Br J Cancer 72: 268–276
Loh KC, Greenspan FS, Gee L, Miller TR and Yeo P (1997) Pathological tumor-node-metastasis (pTNM) staging of papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82: 3553–3562
Malthiery Y and Lissitzky S (1987) Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem 165: 491–498
Mattano LA, Moss TJ and Emerson SG (1992) Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701–4705
Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG and Gomella LG (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110–6112
Noguchi M, Katev N and Miwa K (1998) Therapeutic strategies and long-term results in differentiated thyroid cancer. J Surg Oncol 67: 52–59
Parker SL, Tong T, Bolden S and Wingo PA (1997) Cancer statistics, 1997. Cancer J Clin 47: 5–27
Ringel MD, Ladenson PW and Levine MA (1998) Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83: 4435–4442
Sanders LE and Cady B (1998) Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 133: 419–425
Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, Fragu P, Lumbroso J, Caillou B and Parmentier C (1986) Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63: 960–967
Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297–306
Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB and Panzarella T (1987) Papillary and follicular thyroid cancer. Am J Med 83: 479–488
Tallini G, Ghossein RA, Emanuel J, Gill J, Kinder B, Dimich AB, Costa J, Robbins R, Burrow GN and Rosai J (1998) Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 16: 1158–1166
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Bojunga, J., Röddiger, S., Stanisch, M. et al. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer 82, 1650–1655 (2000). https://doi.org/10.1054/bjoc.1999.1209
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1209
Keywords
This article is cited by
-
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing’s syndrome of different origin
Journal of Endocrinological Investigation (2007)
-
Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma
British Journal of Cancer (2005)
-
Detection of lymph node metastases of papillary thyroid cancer—comparison of the results of histopathology, immunohistochemistry and reverse transcription-polymerase chain reaction—a preliminary report
Langenbeck's Archives of Surgery (2005)
-
Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it?
British Journal of Cancer (2004)
-
Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer
Journal of Cancer Research and Clinical Oncology (2003)